Logopedie bij de ziekte van Parkinson - Logopedie.nl
Logopedie bij de ziekte van Parkinson - Logopedie.nl
Logopedie bij de ziekte van Parkinson - Logopedie.nl
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Literatuur<br />
(1) Morris MS, Iansek RN. <strong>Parkinson</strong>’s disease: a team approach. Melbourne, Australia:<br />
Buscombe Vicprint; 1997.<br />
(2) Marigliani C, Gates S, Jacks D. Speech Pathology and <strong>Parkinson</strong>’s Disease. In: Morris<br />
MS, Iansek RN, editors. <strong>Parkinson</strong>’s disease: a team approach. Melbourne, Australia:<br />
Buscombe Vicprint; 1997.<br />
(3) Miller N, Noble E, Jones D, Burn D. Life with communication changes in <strong>Parkinson</strong>’s<br />
disease. Age Ageing 2006 May;35(3):235-9.<br />
(4) Trail M, Fox C, Ramig LO, Sapir S, Howard J, Lai EC. Speech treatment for <strong>Parkinson</strong>’s<br />
disease. NeuroRehabilitation 2005;20(3):205-21.<br />
(5) Miller N, Noble E, Jones D, Burn D. Hard to swallow: dysphagia in <strong>Parkinson</strong>’s disease.<br />
Age Ageing 2006 Nov;35(6):614-8.<br />
(6) Kwaliteitsinstituut voor <strong>de</strong> gezondheidszorg CBO. Multidisciplinaire richtlijn voor<br />
diagnostiek en behan<strong>de</strong>ling <strong>van</strong> <strong>de</strong> <strong>ziekte</strong> <strong>van</strong> <strong>Parkinson</strong> (in ontwikkeling). Utrecht:<br />
CBO; 2008.<br />
(7) Greene MC, Watson BW, Gay P, Townsend DB. A therapeutic speech amplifier and its<br />
use in speech therapy. Journal of Laryngology and Otology 86[6], 595-605. 1972.<br />
(8) Schulz GM, Grant MK. Effects of speech therapy and pharmacologic and surgical<br />
treatments on voice and speech in <strong>Parkinson</strong>’s disease: a review of the literature.<br />
J Commun Disord 2000 Jan;33(1):59-88.<br />
(9) Pinto S, Ozsancak C, Tripoliti E, Thobois S, Limousin-Dowsey P, Auzou P. Treatments<br />
for dysarthria in <strong>Parkinson</strong>’s disease. Lancet Neurol 2004 Sep;3(9):547-56.<br />
(10) Deane KH, Ellis-Hill C, Jones D, Whurr R, Ben Shlomo Y, Playford ED, et al. Systematic<br />
review of paramedical therapies for <strong>Parkinson</strong>’s disease. Mov Disord 2002<br />
Sep;17(5):984-91.<br />
(11) Suchowersky O, Gronseth G, Perlmutter J, Reich S, Zesiewicz T, Weiner WJ. Practice<br />
Parameter: neuroprotective strategies and alternative therapies for <strong>Parkinson</strong> disease<br />
(an evi<strong>de</strong>nce-based review): report of the Quality Standards Subcommittee of the<br />
American Aca<strong>de</strong>my of Neurology. Neurology 2006 Apr 11;66(7):976-82.<br />
(12) Nijkrake M, Bloem BR, Mulleners W, Oostendorp R, Munneke M. Referral to nonpharmacological<br />
interventions in <strong>Parkinson</strong>’s disease. <strong>Parkinson</strong>ism Relat Disord<br />
2005;11(Supplement 2):S249.<br />
(13) Kalf H, Munneke M. <strong>Logopedie</strong> <strong>bij</strong> <strong>de</strong> <strong>ziekte</strong> <strong>van</strong> <strong>Parkinson</strong>. <strong>Logopedie</strong> en Foniatrie<br />
80[2], 36-40. 2008.<br />
(14) Kwaliteitsinstituut voor <strong>de</strong> gezondheidszorg CBO. Evi<strong>de</strong>nce-based Richtlijnontwikkeling.<br />
Handleiding voor werkgroeple<strong>de</strong>n. November 2007 ed. Utrecht: Kwaliteitsinstituut<br />
voor <strong>de</strong> Gezondheidszorg CBO: ; 2007.<br />
149
Change language